- Home
- BNTC vs ITIC Comparison
BNTC vs ITIC Comparison
Compare BNTC & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTC | ITIC |
|---|---|---|
| Founded | 1995 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 463.3M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BNTC | ITIC |
|---|---|---|
| Price | $12.50 | $233.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 97.6K | 17.1K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | ★ 80.94 | 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | N/A | ★ $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.80 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $9.85 | $190.20 |
| 52 Week High | $17.15 | $288.98 |
Technical Indicators
Market Signals| Indicator | BNTC | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 52.09 |
| Support Level | $11.39 | $230.57 |
| Resistance Level | $13.27 | $249.65 |
| Average True Range (ATR) | 0.65 | 6.58 |
| MACD | -0.10 | -0.77 |
| Stochastic Oscillator | 38.70 | 30.62 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).